Cargando…
How can clinicians, specialty societies and others evaluate and improve the quality of apps for patient use?
BACKGROUND: Health-related apps have great potential to enhance health and prevent disease globally, but their quality currently varies too much for clinicians to feel confident about recommending them to patients. The major quality concerns are dubious app content, loss of privacy associated with w...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276222/ https://www.ncbi.nlm.nih.gov/pubmed/30501638 http://dx.doi.org/10.1186/s12916-018-1211-7 |
_version_ | 1783377972056555520 |
---|---|
author | Wyatt, Jeremy C. |
author_facet | Wyatt, Jeremy C. |
author_sort | Wyatt, Jeremy C. |
collection | PubMed |
description | BACKGROUND: Health-related apps have great potential to enhance health and prevent disease globally, but their quality currently varies too much for clinicians to feel confident about recommending them to patients. The major quality concerns are dubious app content, loss of privacy associated with widespread sharing of the patient data they capture, inaccurate advice or risk estimates and the paucity of impact studies. This may explain why current evidence about app use by people with health-related conditions is scanty and inconsistent. MAIN TEXT: There are many concerns about health-related apps designed for use by patients, such as poor regulation and implicit trust in technology. However, there are several actions that various stakeholders, including users, developers, health professionals and app distributors, can take to tackle these concerns and thus improve app quality. This article focuses on the use of checklists that can be applied to apps, novel evaluation methods and suggestions for how clinical specialty organisations can develop a low-cost curated app repository with explicit risk and quality criteria. CONCLUSIONS: Clinicians and professional societies must act now to ensure they are using good quality apps, support patients in choosing between available apps and improve the quality of apps under development. Funders must also invest in research to answer important questions about apps, such as how clinicians and patients decide which apps to use and which app factors are associated with effectiveness. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12916-018-1211-7) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6276222 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-62762222018-12-06 How can clinicians, specialty societies and others evaluate and improve the quality of apps for patient use? Wyatt, Jeremy C. BMC Med Opinion BACKGROUND: Health-related apps have great potential to enhance health and prevent disease globally, but their quality currently varies too much for clinicians to feel confident about recommending them to patients. The major quality concerns are dubious app content, loss of privacy associated with widespread sharing of the patient data they capture, inaccurate advice or risk estimates and the paucity of impact studies. This may explain why current evidence about app use by people with health-related conditions is scanty and inconsistent. MAIN TEXT: There are many concerns about health-related apps designed for use by patients, such as poor regulation and implicit trust in technology. However, there are several actions that various stakeholders, including users, developers, health professionals and app distributors, can take to tackle these concerns and thus improve app quality. This article focuses on the use of checklists that can be applied to apps, novel evaluation methods and suggestions for how clinical specialty organisations can develop a low-cost curated app repository with explicit risk and quality criteria. CONCLUSIONS: Clinicians and professional societies must act now to ensure they are using good quality apps, support patients in choosing between available apps and improve the quality of apps under development. Funders must also invest in research to answer important questions about apps, such as how clinicians and patients decide which apps to use and which app factors are associated with effectiveness. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12916-018-1211-7) contains supplementary material, which is available to authorized users. BioMed Central 2018-12-03 /pmc/articles/PMC6276222/ /pubmed/30501638 http://dx.doi.org/10.1186/s12916-018-1211-7 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Opinion Wyatt, Jeremy C. How can clinicians, specialty societies and others evaluate and improve the quality of apps for patient use? |
title | How can clinicians, specialty societies and others evaluate and improve the quality of apps for patient use? |
title_full | How can clinicians, specialty societies and others evaluate and improve the quality of apps for patient use? |
title_fullStr | How can clinicians, specialty societies and others evaluate and improve the quality of apps for patient use? |
title_full_unstemmed | How can clinicians, specialty societies and others evaluate and improve the quality of apps for patient use? |
title_short | How can clinicians, specialty societies and others evaluate and improve the quality of apps for patient use? |
title_sort | how can clinicians, specialty societies and others evaluate and improve the quality of apps for patient use? |
topic | Opinion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276222/ https://www.ncbi.nlm.nih.gov/pubmed/30501638 http://dx.doi.org/10.1186/s12916-018-1211-7 |
work_keys_str_mv | AT wyattjeremyc howcancliniciansspecialtysocietiesandothersevaluateandimprovethequalityofappsforpatientuse |